creatine has been researched along with Parkinsonian Disorders in 7 studies
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with pargyline attenuated the MPTP-induced clinical signs, MRI and MRS changes, and the histopathological and immunoreactivity alterations." | 1.32 | Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism. ( Hadjiconstantinou, M; Neff, NH; Podell, M; Smith, MA, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, W | 1 |
| Zheng, Z | 1 |
| Zhuang, W | 1 |
| Chen, D | 1 |
| Wang, X | 2 |
| Sun, X | 1 |
| Fabiani, G | 1 |
| Teive, HA | 1 |
| Munhoz, RP | 1 |
| Valastro, B | 1 |
| Dekundy, A | 1 |
| Danysz, W | 1 |
| Quack, G | 1 |
| Thomas, B | 1 |
| Beal, MF | 2 |
| Podell, M | 1 |
| Hadjiconstantinou, M | 1 |
| Smith, MA | 1 |
| Neff, NH | 1 |
| Klivenyi, P | 1 |
| Gardian, G | 1 |
| Calingasan, NY | 1 |
| Yang, L | 1 |
| Federico, F | 1 |
| Simone, IL | 1 |
| Lucivero, V | 1 |
| Mezzapesa, DM | 1 |
| de Mari, M | 1 |
| Lamberti, P | 1 |
| Petruzzellis, M | 1 |
| Ferrari, E | 1 |
7 other studies available for creatine and Parkinsonian Disorders
| Article | Year |
|---|---|
Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.
Topics: Animals; Aspartic Acid; Cell Differentiation; Cell Survival; Choline; Corpus Striatum; Creatine; Dis | 2013 |
Lentiform fork sign and fluctuating, reversible parkinsonism in a patient with uremic encephalopathy.
Topics: Brain; Brain Diseases, Metabolic; Creatine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; N | 2013 |
Oral creatine supplementation attenuates L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats.
Topics: Administration, Oral; Analysis of Variance; Animals; Creatine; Dietary Supplements; Disease Models, | 2009 |
Mitochondrial therapies for Parkinson's disease.
Topics: Animals; Creatine; Humans; Mitochondria; Parkinsonian Disorders; Ubiquinone | 2010 |
Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Brain; Cats; Choline; Corpus S | 2003 |
Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Topics: Animals; Creatine; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease | 2003 |
Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Creatine; Diagnosis, Differential; Disease Progression; | 1999 |